Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Amlexanox

Next Previous
X
Search
Drug Profile

Amlexanox

Alternative Names: Aftaid; Aphthasol; Aptheal; Apthera; CHX 3673; Miraftil; OraDisc A; OraRinse™

Latest Information Update: 24 Oct 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Takeda
  • Developer Pharmascience; ULURU
  • Class Aminopyridines; Anti-inflammatories; Antiallergics; Antiulcers; Small molecules
  • Mechanism of Action Histamine release inhibitors; Leukotriene inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Aphthous stomatitis

Highest Development Phases

  • Market Withdrawal Aphthous stomatitis
  • Discontinued Atopic dermatitis; Mouth disorders; Mucositis

Most Recent Events

  • 05 Jul 2017 Amlexanox topical patch (OraDisc™ A) is available for licensing in USA as of 05 Jul 2017. https://www.uluruinc.info/
  • 05 Aug 2016 Meda has been acquired by Mylan
  • 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top